Literature DB >> 5899740

Pigmentation due to phenothiazines in high and prolonged dosage.

A Satanove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5899740

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

Review 1.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 2.  Drug eruptions.

Authors:  S K Goolamali
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

3.  Toxic effects of phenothiazines on the eye.

Authors:  D J Boet
Journal:  Doc Ophthalmol       Date:  1970-07-24       Impact factor: 2.379

4.  [In vitro studies on chlorpromazine photoallergy].

Authors:  E G Jung
Journal:  Arch Klin Exp Dermatol       Date:  1970

5.  Ocular melanosis with special reference to chlorpromazine.

Authors:  M E Cameron
Journal:  Br J Ophthalmol       Date:  1967-05       Impact factor: 4.638

6.  Longitudinal pigmentation of the nails in Addison's disease.

Authors:  C F Allenby; P H Snell
Journal:  Br Med J       Date:  1966-06-25

7.  Chlorpromazine melanosis.

Authors: 
Journal:  Br Med J       Date:  1967-09-09

8.  An attempt to reduce the photosensitizing potential of chlorpromazine with the simultaneous use of beta- and dimethyl-beta-cyclodextrins in guinea pigs.

Authors:  T Hoshino; K Ishida; T Irie; K Uekama; T Ono
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

9.  Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.

Authors:  S Lal; D Bloom; B Silver; B Desjardins; B Krishnan; J Thavundayil; T Thompson
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

10.  DTIC and CPZ cytotoxicities on established human melanocyte cell lines.

Authors:  C Aubert; F Rouge
Journal:  Med Oncol Tumor Pharmacother       Date:  1984
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.